KLK3 and Familial prostate cancer: In recent years, significant progress has been made in the early diagnosis and treatment of prostate cancer through widespread screening based on Prostate-Specific Antigen (PSA), the application of multiparametric magnetic resonance imaging (mpMRI), and the use of composite predictive indicators, such as the Prostate Health Index (PHI) [2–4].